ADMA Biologics
ADMA
#2918
Rank
A$6.73 B
Marketcap
$28.47
Share price
-3.19%
Change (1 day)
201.45%
Change (1 year)

Earnings for ADMA Biologics (ADMA)

Earnings in 2024 (TTM): A$0.13 Billion

According to ADMA Biologics 's latest financial reports the company's current earnings are A$0.38 Billion. In 2023 the company made an earning of -A$5.11 Million, an increase over its 2022 earnings that were of -A$74.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ADMA Biologics from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.13 B-2736.12%
2023 -A$5.11 Million-93.11%
2022 -A$74.13 Million-20.42%
2021 -A$93.15 Million-8.11%
2020 -A$0.11 Billion62.31%
2019 -A$62.46 Million-34.76%
2018 -A$95.74 Million48.79%
2017 -A$64.35 Million134.28%
2016 -A$27.47 Million7.12%
2015 -A$25.64 Million0.3%
2014 -A$25.57 Million7.85%
2013 -A$23.71 Million71.04%
2012 -A$13.86 Million28864%
2011 -A$0.05 Million35.22%
2010 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.42 Billion-390.36%๐Ÿ‡บ๐Ÿ‡ธ USA
A$30.55 M-78.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$42.24 Million-129.31%๐Ÿ‡บ๐Ÿ‡ธ USA